MyFinsight
Home
Blog
About
Cash and cash
equivalents
$41,148K
(56.40%↑ Y/Y)
Marketable securities
$15,878K
(-91.49%↓ Y/Y)
Prepaid expenses and
other current assets
$9,594K
(-37.71%↓ Y/Y)
Receivable from contracts
with collaborators
$6,105K
(-19.45%↓ Y/Y)
Total current assets
$72,725K
(-69.17%↓ Y/Y)
Operating lease
right-of-use assets
$3,658K
(-19.92%↓ Y/Y)
Other assets
$429K
(12.01%↑ Y/Y)
Property and equipment,
net
$55K
(-27.63%↓ Y/Y)
Total assets
$76,867K
(-68.10%↓ Y/Y)
Accumulated deficit
-$1,468,702K
(-9.32%↓ Y/Y)
Accumulated other
comprehensive loss
-$3,734K
(26.61%↑ Y/Y)
Total liabilities and
stockholders' deficit
$76,867K
(-68.10%↓ Y/Y)
Total stockholders'
deficit
-$94,029K
(-103.94%↓ Y/Y)
Additional paid-in capital
$1,378,357K
(5.83%↑ Y/Y)
Common stock, 0.0001
par value...
$50K
(117.39%↑ Y/Y)
Total liabilities
$170,896K
(-40.46%↓ Y/Y)
Total current
liabilities
$137,783K
(157.09%↑ Y/Y)
Long-term contract
liabilities
$30,155K
(-4.25%↓ Y/Y)
Operating lease
liabilities - long-term
$2,958K
(-24.81%↓ Y/Y)
Embedded derivative
liability at fair value
$42,938K
Current convertible
senior notes
$36,145K
Warrant liability at
fair value
$18,291K
Accrued expenses and
other current...
$17,710K
(40.06%↑ Y/Y)
Accrued research and
development expenses
$9,680K
(-37.95%↓ Y/Y)
Current contract
liabilities
$7,068K
(-69.89%↓ Y/Y)
Accounts payable
$5,951K
(217.22%↑ Y/Y)
Back
Back
Balance Sheet
Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. (GOSS)
source: myfinsight.com